Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2020
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
9,453
+4.73%
|
-
|
|
Aug 03
2020
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
6,576
+8.16%
|
-
|
|
Aug 03
2020
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
8,117
+13.0%
|
-
|
|
Aug 03
2020
|
John R Liddicoat EVP & President of Americas |
BUY
Grant, award, or other acquisition
|
Direct |
3,905
+8.54%
|
-
|
|
Aug 03
2020
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,118
+22.18%
|
-
|
|
Aug 03
2020
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,042
+9.31%
|
-
|
|
Aug 03
2020
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
4,932
+14.96%
|
-
|
|
Aug 03
2020
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,727
+8.79%
|
-
|
|
Aug 03
2020
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
5,754
+8.42%
|
-
|
|
Aug 03
2020
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
6,576
+25.86%
|
-
|
|
Aug 03
2020
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
7,398
+11.4%
|
-
|
|
Jul 31
2020
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
7,922
-4.19%
|
$760,512
$96.48 P/Share
|
|
Jul 31
2020
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
26,082
-4.44%
|
$2,503,872
$96.48 P/Share
|
|
Jul 31
2020
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,482
-6.23%
|
$430,272
$96.48 P/Share
|
|
Jul 31
2020
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,411
-10.48%
|
$519,456
$96.48 P/Share
|
|
Jul 31
2020
|
John R Liddicoat EVP & President of Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
2,269
-5.65%
|
$217,824
$96.48 P/Share
|
|
Jul 31
2020
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,252
-6.83%
|
$408,192
$96.48 P/Share
|
|
Jul 31
2020
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,339
-7.43%
|
$608,544
$96.48 P/Share
|
|
Jul 31
2020
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
2,569
-10.0%
|
$246,624
$96.48 P/Share
|
|
Jul 31
2020
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,554
-7.42%
|
$341,184
$96.48 P/Share
|
|
Jul 31
2020
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
3,677
-6.07%
|
$352,992
$96.48 P/Share
|
|
Jul 31
2020
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
1,100
-8.22%
|
$105,600
$96.48 P/Share
|
|
Jul 31
2020
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,727
-5.16%
|
$261,792
$96.48 P/Share
|
|
Jun 30
2020
|
Omar Ishrak Executive Chairman |
BUY
Bona fide gift
|
Indirect |
22,508
+50.0%
|
-
|
|
Jun 30
2020
|
Omar Ishrak Executive Chairman |
SELL
Bona fide gift
|
Direct |
22,508
-3.71%
|
-
|
|
Jun 01
2020
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
915
+33.52%
|
-
|
|
Jun 01
2020
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
915
-0.36%
|
-
|
|
May 29
2020
|
Carol A Surface EVP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,000
-4.05%
|
$194,000
$97.72 P/Share
|
|
Apr 29
2020
|
Richard H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-0.4%
|
$38,907
$99.14 P/Share
|
|
Apr 29
2020
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-1.21%
|
$38,907
$99.14 P/Share
|
|
Apr 29
2020
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-3.08%
|
$38,907
$99.14 P/Share
|
|
Apr 29
2020
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
51
-2.55%
|
$5,049
$99.14 P/Share
|
|
Apr 29
2020
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-1.01%
|
$38,907
$99.14 P/Share
|
|
Apr 29
2020
|
James T Lenehan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-0.69%
|
$38,907
$99.14 P/Share
|
|
Apr 29
2020
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-4.01%
|
$38,907
$99.14 P/Share
|
|
Apr 29
2020
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-0.58%
|
$38,907
$99.14 P/Share
|
|
Apr 29
2020
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
393
-1.14%
|
$38,907
$99.14 P/Share
|
|
Apr 27
2020
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+1.75%
|
-
|
|
Apr 27
2020
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+5.09%
|
-
|
|
Apr 27
2020
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+11.99%
|
-
|
|
Apr 27
2020
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+46.48%
|
-
|
|
Apr 27
2020
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+4.27%
|
-
|
|
Apr 27
2020
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+7.9%
|
-
|
|
Apr 27
2020
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+2.97%
|
-
|
|
Apr 27
2020
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+15.05%
|
-
|
|
Apr 27
2020
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+2.51%
|
-
|
|
Apr 27
2020
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,737
+4.8%
|
-
|
|
Apr 03
2020
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
929
-1.4%
|
$79,894
$86.27 P/Share
|
|
Apr 03
2020
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,813
+2.65%
|
$79,772
$44.13 P/Share
|
|
Feb 20
2020
|
Omar Ishrak Executive Chairman |
BUY
Open market or private purchase
|
Direct |
8,771
+1.43%
|
$991,123
$113.68 P/Share
|